(Q72092557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

L Gorelik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A Prokhorova

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M B Mokyr

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

117-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients

23 October 2019

cites work

1 reference

12 December 2020

Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy

1 reference

12 December 2020

Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)

1 reference

12 December 2020

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

12 December 2020

Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.

1 reference

12 December 2020

Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers

1 reference

12 December 2020

Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide

1 reference

12 December 2020

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

1 reference

12 December 2020

Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures

1 reference

12 December 2020

Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay

1 reference

12 December 2020

Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

1 reference

12 December 2020

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

1 reference

12 December 2020

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1

1 reference

12 December 2020

Characterization of the exogenous interleukin-2 requirements for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers

1 reference

12 December 2020

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo

1 reference

12 December 2020

Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor

1 reference

12 December 2020

Involvement of TCR-V beta 8.3+ cells in the cure of mice bearing a large MOPC-315 tumor by low dose melphalan

1 reference

12 December 2020

Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide

1 reference

12 December 2020

Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma

1 reference

12 December 2020

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases

1 reference

12 December 2020

EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ANTIBODY PRODUCTION IN MAN; A PRELIMARY REPORT

1 reference

12 December 2020

Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.

1 reference

12 December 2020

Effects of interferon-gamma on the activation of human T lymphocytes

1 reference

12 December 2020

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

1 reference

12 December 2020

Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy

1 reference

12 December 2020

Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat

1 reference

12 December 2020

In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration

1 reference

12 December 2020

Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.

1 reference

12 December 2020

Interleukin-12 and its role in the generation of TH1 cells

1 reference

12 December 2020

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

1 reference

12 December 2020

Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected].

1 reference

12 December 2020

Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice.

1 reference

12 December 2020

Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice

1 reference

12 December 2020

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

12 December 2020

Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig.

1 reference

12 December 2020

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

1 reference

12 December 2020

Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma

1 reference

12 December 2020

Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.

1 reference

12 December 2020

Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma

1 reference

12 December 2020

A family of beta 7 integrins on human mucosal lymphocytes

1 reference

12 December 2020

Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

1 reference

12 December 2020

1 reference

12 December 2020

Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.

1 reference

12 December 2020

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01525317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8044831%20AND%20SRC:MED&resulttype=core&format=json